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Purpose: Fatigue-induced microcracking is a common, naturally occurring phenomenon in articular 
calcified cartilage and subchondral bone (SCB). These microcracks are, in some cases, healed by 
infilling with and mineralisation of an aqueous matrix. High density mineralised protrusions (HDMP) 
of the same matrix from the tidemark mineralising front into hyaline articular cartilage (HAC) form as 
an aberrant by-product of this aresorptive repair mechanism. First discovered in equine joints, 
HDMPs have now been confirmed on the articular surfaces of femoral heads in humans with 
ochronotic and conventional osteoarthritis (OA). Possessed of mineral concentrations greater than 
any healthy joint tissue and a propensity to disintegrate within HAC, HDMPs undoubtedly affect the 
biomechanical performance of surrounding tissues and have been identified as one of the earliest 
detectable morphological changes in OA models. With this in mind, the fact that they arise through 
normal physiological processes is suggestive of a significant role in the development of arthropathy 
in incident joints. They are best seen by study of undecalcified tissue blocks but can be studied 
noninvasively by magnetic resonance imaging (MRI) and x-ray computed microtomography (µCT). 
The debilitating effects of OA are seen in many weight bearing joints, but human studies of HDMPs 
have been hitherto limited to ex-vivo hips. We prospect for them in the knee and compare their 
radiological appearance between ex- and in-vivo subject groups. 
Methods: Twenty-three osteoarthritic cadaveric knees were dissected and each placed inside a 
circularly polarised wrist coil before being imaged by three dimensional dual-echo steady state (3D 
DESS) MR with water excitation using a 3T Siemens Trio. Variations in sample size produced isotropic 
image data with resolutions of between 0.26 and 0.48mm. A subset of 13 knees were further 
dissected and subjected to µCT with a 120kV Nikon XT225 scanner. Isometric voxels were 
reconstructed to produce tomographs with in-plane resolutions of 20-83µm. Cadaveric findings were 
compared to clinical data obtained from the Osteoarthritis Initiative (OAI), a longitudinal survey of 
knee OA. Twenty-one patients were selected from the OAI progression cohort, for whom bilateral 
knee MRI – including 3D DESS sequences – had been acquired with a similar 3T Siemens Trio system. 
Information on the radiological appearance of HDMPs from the literature was used to prospect for 
them in ex-vivo MRI. These findings were compared with µCT for validation. OAI imaging data were 
then surveyed for HDMPs using the same criteria. The appearance of HDMPs identified in-vivo was 
compared to validated ex-vivo findings to assess the viability of clinical scanning technology as an 
identification tool for HDMPs, in-vivo. 
Results: HDMPs were identified in 19 of 23 ex-vivo knees by DESS MRI. These were identified as 
features of low signal yield extending from the SCB into HAC. Highly mineralised structures were 
confirmed in 5 of 13 knees by µCT. Figure 1 shows examples of HDMPs identified, ex-vivo. Seventeen 
of twenty-one OAI patients exhibited ≥1 HDMP in at least one knee at baseline visit. Image data from 
subsequent annual scans showed the persistence and development of many HDMPs, such as the 
example shown in figure 2. Whilst HDMPs are variable in their size and shape, their general 
appearance in DESS scans of OAI patients is consistent with those seen in the higher quality images 
of ex-vivo joints. 
 
 
Conclusions: We observe HDMPs in the human knee joint for the first time; HDMPs do form in knees 
with structural OA and they are identifiable by 3D DESS MRI. Confirmation of HDMP density by µCT 
validates this finding. Instances of ex-vivo DESS identification which did not achieve µCT validation 
may be artefactual, or indicate the natural history of HDMPs – known to be brittle – fragmented 
under loading. Persistence of HDMPs in consecutive annual scans indicates those identified in OAI 
patients are unlikely to be artefact. The apparent similarity of HDMPs identified in-vivo and ex-vivo 
by similar MR sequences demonstrates the feasibility of DESS as an HDMP detection method that 
can be used clinically. Given the links made between HDMPs and the development of OA, evidence 
of their presence in knee joints may be significant in developing a better understanding the OA 
pathogenesis. With refinement, DESS may constitute a reliable identification method for HDMPs 
sufficient for their presence to be considered a potential imaging biomarker for predicting joint 
destruction in some forms of OA. 
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